Adherium Listed in 2015 Global Digital Health Top 100
29 December 2015, Melbourne, Australia: Adherium Limited (ASX: ADR), a global leader in digital health technologies which address sub-optimal medication use in chronic disease, has been recognised for the second time* as one of the world’s top 100 companies in Innovation in Mobile, Digital and Connected Healthcare according to a US judging panel at Global Digital Health Journal.
Reflecting the growing prominence of mobile, digital and connected solutions in the healthcare sector, the Global Digital Health 100 seeks to identify the organisations that are transforming, or have the potential to transform, and disrupt the way in which healthcare is delivered. The list covers technologies targeting diverse areas of healthcare including clinical solutions, wearable technologies, healthcare applications, medical devices and data analytics.
The final list was a result of 6 months of judging and analysis by the Journal’s editorial and advisory panel and covered 10 quantitative and qualitative evaluation metrics including disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and, industry integration.
“The Global Digital Health Journal is a respected and authoritative source in Adherium’s area of specialisation. Our ranking in this list is a result of the quality and importance of our innovations and the increasing international profile we are building,” said Mr Garth Sutherland, Group CEO of Adherium.
“Adherium is just one of seven companies in the list not domiciled in the US or Europe. We are delighted to have our work to use digital technologies to transform the lives of those with chronic disease recognised in this way.”
For more information on the Global Digital Health 100 please Click Here.
*Adherium subsidiary Adherium (NZ) Ltd, formerly Nexus6, was recognised in the Global Digital Health 100 2014.